Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2021 07:00 ET | Source: NeRRe Therapeutics

NeRRe Therapeutics raises £20 million in a Series B2 financing round

NeRRe Therapeutics raises £20 million in a Series B2 financing round New funds to evaluate orvepitant as a treatment for the disabling chronic cough associated with idiopathic pulmonary fibrosis...
July 07, 2021 02:00 ET | Source: NeRRe Therapeutics

NeRRe Therapeutics raises £20 million in a Series B2 financing round

NeRRe Therapeutics raises £20 million in a Series B2 financing round New funds to evaluate orvepitant as a treatment for the disabling chronic cough associated with idiopathic pulmonary fibrosis...
June 07, 2019 07:00 ET | Source: NeRRe Therapeutics

NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough

NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough ~ Statistically significant and clinically relevant improvements in patient reported outcomes in...
June 07, 2019 02:00 ET | Source: NeRRe Therapeutics

NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough

NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough ~ Statistically significant and clinically relevant improvements in patient reported outcomes in...